Feed Preview

Fast Growing

MS: Therapies

MS: Therapies diagram by Molecular Sensei, Shutterstock
Molecular Sensei, Shutterstock

The feed focuses on therapeutic interventions used to treat Multiple Sclerosis.

Top 20 most recent papers
Annals of Neurology

Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis

Annals of NeurologyJanuary 24, 2020
Burcu ZeydanKejal Kantarci
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research

Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study

Clinical Cancer Research : an Official Journal of the American Association for Cancer ResearchJanuary 24, 2020
Michael J BurkePatrick A Brown
Multiple Sclerosis : Clinical and Laboratory Research

Recovery of cognitive function after relapse in multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory ResearchJanuary 24, 2020
Ralph Hb BenedictBianca Weinstock-Guttman
ACS Applied Materials & Interfaces

Pentagram-shaped Ag@Pt core-shell nanostructures as high-performance catalyst for formaldehyde detection

ACS Applied Materials & InterfacesJanuary 23, 2020
Dongsheng XuXinxin Li
Revue médicale suisse

Neurology 2019

Revue médicale suisseJanuary 22, 2020
Matthieu PerrenoudRenaud Du Pasquier
1
Multiple Sclerosis : Clinical and Laboratory Research

A novel classification of fatigue in multiple sclerosis based on longitudinal assessments

Multiple Sclerosis : Clinical and Laboratory ResearchJanuary 24, 2020
Miklos PalotaiCharles Rg Guttmann
Journal of the Neurological Sciences

Progressive myelopathy associated with spinal epidural lipomatosis in three non-obese patients with type 1 diabetes mellitus

Journal of the Neurological SciencesJanuary 24, 2020
Itay LotanIlya Kister
Expert Opinion on Drug Safety

Polypharmacy among patients with multiple sclerosis: a qualitative systematic review

Expert Opinion on Drug SafetyJanuary 23, 2020
Niklas FrahmUwe Klaus Zettl
1
Frontiers in Pharmacology

Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis

Frontiers in PharmacologyJanuary 24, 2020
Stéphanie HostenbachJacques De Keyser
Multiple Sclerosis and Related Disorders

Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift®)

Multiple Sclerosis and Related DisordersJanuary 24, 2020
Sebastian MichelsMakbule Senel
Physiological Measurement

Upper and lower limb performance fatigability in persons with multiple sclerosis investigated through surface electromyography: a pilot study

Physiological MeasurementJanuary 24, 2020
Matteo Beretta-PiccoliJens Bansi
Multiple Sclerosis : Clinical and Laboratory Research

Toward biologically meaningful categories of MS-related fatigue

Multiple Sclerosis : Clinical and Laboratory ResearchJanuary 24, 2020
Stephen C Krieger, James F Sumowski
bioRxiv

ER stress in the dorsal root ganglia regulates BK channel physiology and contributes to pain hypersensitivity in a mouse model of multiple sclerosis

bioRxivJanuary 23, 2020
Muhammad Saad YousufBradley J Kerr
Multiple Sclerosis : Clinical and Laboratory Research

A critical analysis of helminth immunotherapy in multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory ResearchJanuary 24, 2020
Marc CharabatiLisa C Osborne
Expert Review of Neurotherapeutics

Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment

Expert Review of NeurotherapeuticsJanuary 24, 2020
Aurora ZanghìFrancesco Patti
ACS Chemical Neuroscience

Potential neuroprotective effect of the HMGB1 inhibitor Glycyrrhizin in neurological disorders

ACS Chemical NeuroscienceJanuary 24, 2020
Yam Nath PaudelMohd Farooq Shaikh
Neuropsychological Rehabilitation

Combined virtual reality and physical training improved the bimanual coordination of women with multiple sclerosis

Neuropsychological RehabilitationJanuary 24, 2020
Ebrahim NorouziSerge Brand
Neural Regeneration Research

Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014-2019

Neural Regeneration ResearchJanuary 22, 2020
Bridget Martinez, Philip V Peplow
3
Frontiers in Cellular Neuroscience

Dynamic Balance of Microglia and Astrocytes Involved in the Remyelinating Effect of Ginkgolide B

Frontiers in Cellular NeuroscienceJanuary 24, 2020
Jun-Jun YinCun-Gen Ma
Curēus

Assessment of the Burden of Multiple Sclerosis Patients' Caregivers in Saudi Arabia

CurēusJanuary 23, 2020
Hussein AlgahtaniFaisal Alkahtani
1

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/ms-therapies/8225165c-32ef-48e6-8979-3ff53ccb5b03